Condensed Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities:
Net loss	$ (1,513,172)	$ (4,948,707)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Stock-based compensation	559,436	667,338
Depreciation	14,634	17,709
Non-cash interest expense	1,378
Changes in operating assets and liabilities
Accounts receivable	(10,000,000)
Prepaid expenses and other current assets	(9,827,700)	182,837
Accounts payable	(1,243,184)	(216,290)
Accrued expenses	(1,554,676)
Deferred collaboration funding	16,715,764
Other current liabilities	9,852,524	(773,267)
Net cash provided by (used in) operating activities	3,005,004	(5,070,380)
Cash flows from investing activities:
Purchase of property and equipment	(5,322)
Net cash used in investing activities	(5,322)
Cash flows from financing activities:
Proceeds from issuance of common stock, net of issuance costs	3,139,047
Receipt of funds from secured loan	4,000,000
Net cash provided by financing activities	7,139,047
Net increase (decrease) in cash and cash equivalents	10,138,729	(5,070,380)
Cash and cash equivalents, beginning of period	5,761,568	12,077,640
Cash and cash equivalents, end of period	$ 15,900,297	$ 7,007,260